IDH1 and oligodendroglioma: Recent observation of changes in TP53 expression in sequential samples of oligodendrogliomas supports that the de novo TP53 mutation or the proliferation of a subset of cells with nuclear expression of TP53 could lead to tumor progression in some IDH1-mutated oligodendroglial tumors [17].